Ledger.Open graph →
SEC Form D · Amendment · filed November 4, 2011

SELEXYS PHARMACEUTICALS CORP

Offering
$5.0M
Sold
$5.0M
Exemption
—
Industry
Biotechnology
Location
OKLAHOMA CITY, OK
Type
—

People & firms on this filing (12)

David Falconer · Edmond, OKExecTom Walker · Oklahoma City, OKDirectorScott Rollins, Ph.D · Edmond, OKExec · DirectorWilliam Paiva, Ph.D · Tulsa, OKDirectorPhilip Jones, M.D · Norman, OKDirectorJurg Schappi · Dublin, IrelandExecNicolas Motelay · Dublin, IrelandDirectorRandy Maksymowich · Calgary, Alberta, CanadaExec · DirectorJames Davis · Calgary, Alberta, CanadaDirectorRichard H. Schweitzer · Los Angeles, CADirectorMark Newman · West Melbourne, FLExec · DirectorDov Zakheim · West Melbourne, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗